As of 4:02pm ET
| +0.13 / +0.16%|
The 14 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 83.50, with a high estimate of 89.00 and a low estimate of 66.00. The median estimate represents a +4.73% increase from the last price of 79.73.
The current consensus among 20 polled investment analysts is to Hold stock in St. Jude Medical. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.